Elevated expression of cancer/testis antigen FSIP1 in ER-positive Breast Tumors

• Cheng YH , WongEW, ChengCY. Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis. Spermatogenesis1(3), 209–220 (2011).
   PubMedGoogle Scholar
• Simpson AJ , CaballeroOL, JungbluthA, ChenYT, OldLJ. Cancer/testis antigens, gametogenesis and cancer. Nat. Rev. Cancer5(8), 615–625 (2005).
   PubMed Web of Science ®Google Scholar
• Ross MT , GrafhamDV, CoffeyAJet al. The DNA sequence of the human X chromosome. Nature 434(7031), 325–337 (2005).
   PubMed Web of Science ®Google Scholar
• Weber J , SalgallerM, SamidDet al. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2´-deoxycytidine. Cancer Res. 54(7), 1766–1771 (1994).
   PubMed Web of Science ®Google Scholar
• De Smet C , De BackerO, FaraoniI, LurquinC, BrasseurF, BoonT. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.Proc. Natl Acad. Sci. USA93(14), 7149–7153 (1996).
   PubMed Web of Science ®Google Scholar
• Roman-Gomez J , Jimenez-VelascoA, AgirreXet al. Epigenetic regulation of human cancer/testis antigen gene, HAGE, in chronic myeloid leukemia. Haematologica 92(2), 153–162 (2007).
   PubMed Web of Science ®Google Scholar
• Renaud S , PugachevaEM, DelgadoMDet al. Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors. Nucleic Acids Res. 35(21), 7372–7388 (2007).
   PubMed Web of Science ®Google Scholar
• Yan M , HimoudiN, BasuBPet al. Increased PRAME antigen-specific killing of malignant cell lines by low avidity CTL clones, following treatment with 5-aza-2´-deoxycytidine. Cancer Immunol. Immunother. 60(9), 1243–1255 (2011).
   PubMed Web of Science ®Google Scholar
• Qiu X , HotherC, RalfkiærUMet al. Equitoxic doses of 5-azacytidine and 5-aza-2´deoxycytidine induce diverse immediate and overlapping heritable changes in the transcriptome. PLoS ONE 5(9), e12994 (2010).
   PubMed Web of Science ®Google Scholar
• Okabayashi K , FujitaT, MiyazakiJet al. Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer. Cancer Sci. 103(9), 1617–1624 (2012).
   PubMed Web of Science ®Google Scholar
• Gure AO , ChuaR, WilliamsonBet al. Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer. Clin. Cancer Res. 11(22), 8055–8062 (2005).
   PubMed Web of Science ®Google Scholar
• Andrade VC , VettoreAL, FelixRSet al. Prognostic impact of cancer/testis antigen expression in advanced stage multiple myeloma patients. Cancer Immun. 8, 2 (2008).
   PubMedGoogle Scholar
• Kurashige T , NoguchiY, SaikaTet al. Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade. Cancer Res. 61(12), 4671–4674 (2001).
   PubMed Web of Science ®Google Scholar
• Brasseur F , RimoldiD, LienardDet al. Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int. J. Cancer 63(3), 375–380 (1995).
   PubMed Web of Science ®Google Scholar
• van der Bruggen P , TraversariC, ChomezPet al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254(5038), 1643–1647 (1991).
   PubMed Web of Science ®Google Scholar
• Jager E , StockertE, ZidianakisZet al. Humoral immune responses of cancer patients against ‘cancer-testis‘ antigen NY-ESO-1: correlation with clinical events. Int. J. Cancer 84(5), 506–510 (1999).
   PubMed Web of Science ®Google Scholar
• Silva WA Jr, GnjaticS, RitterEet al. PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses. Cancer Immun. 7, 18 (2007).
   PubMedGoogle Scholar
• Meek DW , MarcarL. MAGE-A antigens as targets in tumour therapy. Cancer Lett.324(2), 126–132 (2012).
   PubMed Web of Science ®Google Scholar
• Sang M , LianY, ZhouX, ShanB. MAGE-A family: attractive targets for cancer immunotherapy. Vaccine29(47), 8496–8500 (2011).
   PubMed Web of Science ®Google Scholar
• Caballero OL , ChenYT. Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci.100(11), 2014–2021 (2009).
   PubMed Web of Science ®Google Scholar
• Goldman B , DeFrancescoL. The cancer vaccine roller coaster. Nat. Biotechnol.27(2), 129–139 (2009).
   PubMed Web of Science ®Google Scholar
• Scanlan MJ , SimpsonAJ, OldLJ. The cancer/testis genes: review, standardization, and commentary. Cancer Immun.4, 1 (2004).
   PubMedGoogle Scholar
• Theurillat JP , IngoldF, FreiCet al. NY-ESO-1 protein expression in primary breast carcinoma and metastases: correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltration. Int. J. Cancer 120(11), 2411–2417 (2007).
   PubMed Web of Science ®Google Scholar
• Bandic D , JureticA, SarcevicBet al. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study. Croat. Med. J. 47(1), 32–41 (2006).
   PubMed Web of Science ®Google Scholar
• Grigoriadis A , CaballeroOL, HoekKSet al. CT-X antigen expression in human breast cancer. Proc. Natl Acad. Sci. USA 106(32), 13493–13498 (2009).
   PubMed Web of Science ®Google Scholar
• Chen YT , RossDS, ChiuRet al. Multiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers. PLoS ONE 6(3), e17876 (2011).
   PubMed Web of Science ®Google Scholar
• Ademuyiwa FO , BsharaW, AttwoodKet al. NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer. PLoS ONE 7(6), e38783 (2012).
   PubMed Web of Science ®Google Scholar
• Chapman KB , PrendesMJ, SternbergHet al. COL10A1 expression is elevated in diverse solid tumor types and is associated with tumor vasculature. Future Oncol. 8(8), 1031–1040 (2012).
   PubMed Web of Science ®Google Scholar
• Brown PR , MikiK, HarperDB, EddyEM. A-kinase anchoring protein 4 binding proteins in the fibrous sheath of the sperm flagellum. Biol. Reprod.68(6), 2241–2248 (2003).
   PubMed Web of Science ®Google Scholar
• Radvanyi L , Singh-SandhuD, GallichanSet al. The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. Proc. Natl Acad. Sci. USA 102(31), 11005–11010 (2005).
   PubMed Web of Science ®Google Scholar
• Jungbluth AA , StockertE, ChenYTet al. Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours. Br. J. Cancer 83(4), 493–497 (2000).
   PubMed Web of Science ®Google Scholar
• Labhart P , KarmakarS, SalicruEMet al. Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator. Proc. Natl Acad. Sci. USA 102(5), 1339–1344 (2005).
   PubMed Web of Science ®Google Scholar
• Anzick SL , KononenJ, WalkerRLet al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277(5328), 965–968 (1997).
   PubMed Web of Science ®Google Scholar
• Torres-Arzayus MI , Font De MoraJ, YuanJet al. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 6(3), 263–274 (2004).
   PubMed Web of Science ®Google Scholar
• Chiriva-Internati M . Sperm protein 17: clinical relevance of a cancer/testis antigen, from contraception to cancer immunotherapy, and beyond. Int. Rev. Immunol.30(2–3), 138–149 (2011).
   PubMed Web of Science ®Google Scholar
• Chiriva-Internati M , WangZ, SalatiE, BummK, BarlogieB, LimSH. Sperm protein 17 (Sp17) is a suitable target for immunotherapy of multiple myeloma. Blood100(3), 961–965 (2002).
   PubMed Web of Science ®Google Scholar
• Wen Y , RichardsonRT, WidgrenEE, O‘RandMG. Characterization of Sp17: a ubiquitous three domain protein that binds heparin. Biochem. J.357(Pt 1), 25–31 (2001).
   PubMed Web of Science ®Google Scholar
• Gjerstorff MF , DitzelHJ. Limited SP17 expression within tumors diminishes its therapeutic potential. Tissue Antigens80(6), 523–527 (2012).
   PubMedGoogle Scholar
• Lea IA , WidgrenEE, O‘RandMG. Association of sperm protein 17 with A-kinase anchoring protein 3 in flagella. Reprod. Biol. Endocrinol.2, 57 (2004).
   PubMedGoogle Scholar
• Cappell KM , SinnottR, TausP, MaxfieldK, ScarbroughM, WhitehurstAW. Multiple cancer testis antigens function to support tumor cell mitotic fidelity. Mol. Cell. Biol.32(20), 4131–4140 (2012).
   PubMed Web of Science ®Google Scholar
• Geldmacher A , FreierA, LoschFO, WaldenP. Therapeutic vaccination for cancer immunotherapy: antigen selection and clinical responses. Human Vaccin.7(Suppl.), 115–119 (2011).
   PubMed Web of Science ®Google Scholar
• Lim SH , ZhangY, ZhangJ. Cancer-testis antigens: the current status on antigen regulation and potential clinical use. Am. J. Blood Res.2(1), 29–35 (2012).
   PubMedGoogle Scholar

▪ Website

• American Cancer Society. Cancer Facts & Figures 2012. www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf
   Google Scholar